Proteostasis Therapeutics Inc. Secures $45,000,000 Series A Financing

  • Feed Type
  • Date
    8/25/2008
  • Company Name
    Proteostasis Therapeutics Inc.
  • Mailing Address
    Undisclosed Cambridge, MA 02138
  • Company Description
    Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s Proteostasis Network, which maintains the body’s natural protein homeostasis to protect us from numerous diseases. We call these new therapies “Proteostasis RegulatorsTM” and will develop them as novel therapies to treat multiple genetic and degenerative disorders associated with protein homeostasis deficiencies, such as emphysema, type II diabetes, Alzheimer’s Disease and Huntington’s Disease.
  • Website
    http://www.proteostasis.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $45,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The funding was done to develop Proteostasis Regulator(TM)Drugs.
  • M&A Terms
  • Venture Investor
    HealthCare Ventures
  • Venture Investor
    Fidelity BioSciences
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Novartis BioVenture Fund
  • Venture Investor
    Genzyme Ventures

By posting a comment, you agree to our terms and conditions.